Home › Therapeutic areas › Dermatology

Dermatology (37 companies · 20 conditions)

Conditions

Companies

Ticker Company Therapeutic areas In Dermatology Lead stage Mkt cap Programs
AARD Aardvark Therapeutics DermatologyMetabolic+1 Rare 1 Phase 3 $25.2M 3
ABSI Absci DermatologyGI/Hepatology+1 1 Phase 1 $1.31B 6
ACRS Aclaris Therapeutics DermatologyGI/Hepatology+1 Rare 4 Phase 2 $536M 7
ALDX Aldeyra Therapeutics DermatologyOncology+1 1 NDA Submitted $41.9M 5
ALMS Alumis DermatologyImmunology+1 1 Phase 3 $628M 5
ANAB AnaptysBio DermatologyGI/Hepatology+2 Rare 1 Approved $1.36B 9
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 3 Phase 2 — 9
RCUS Arcus Biosciences DermatologyImmunology+1 1 Phase 3 $2.36B 8
BCRX Biocryst Pharmaceuticals DermatologyImmunology+1 Rare 1 Approved $1.93B 4
CABA Cabaletta Bio DermatologyImmunology+2 Rare 1 Phase 2 $220M 8
CLDX Celldex Therapeutics DermatologyImmunology+1 1 Phase 3 $2.20B 6
CRVS Corvus Pharmaceuticals DermatologyOncology+1 Rare 2 Phase 3 $858M 7
ELOX Eloxx Pharmaceuticals DermatologyRenal Rare 2 Phase 2 $48.0M 4
ENTA Enanta Pharmaceuticals DermatologyImmunology+2 1 Approved $253M 8
EVMN Evommune DermatologyImmunology+1 1 Phase 2 $290M 6
FBRX Forte Biosciences DermatologyGI/Hepatology 2 Phase 2 — 3
FBIO Fortress Biotech DermatologyHematology+4 Rare 3 Approved $61.4M 16
IMCR Immunocore DermatologyInfectious Disease+2 1 Approved $1.44B 12
INMB Inmune Bio Dermatology Rare 1 Phase 3 $29.7M 1
KYMR Kymera Therapeutics DermatologyImmunology+1 Rare 2 Phase 2 $10.4B 5
GLUE Monte Rosa Therapeutics CardiovascularDermatology+3 Rare 1 Phase 2 $775M 7
MLTX MoonLake Immunotherapeutics DermatologyImmunology Rare 1 NDA Submitted $957M 4
NKTR Nektar Therapeutics DermatologyImmunology+2 2 Phase 3 $1.23B 11
ORKA Oruka Therapeutics DermatologyImmunology Rare 4 Phase 2 $6.53B 7
PTGX Protagonist Therapeutics DermatologyHematology+2 Rare 2 Approved $8.14B 12
TARA Protara Therapeutics DermatologyMetabolic+1 Rare 1 Phase 3 $143M 3
QTTB Q32 Bio Dermatology 1 Phase 2 $258M 3
QNRX Quoin Pharmaceuticals DermatologyImmunology Rare 2 Phase 2 $236M 4
RLAY Relay Therapeutics DermatologyOncology Rare 1 Approved $3.64B 4
RVPH Reviva Pharmaceuticals CardiovascularDermatology+3 Rare 1 Phase 3 $4.7M 11
SGMT Sagimet Biosciences DermatologyMetabolic 2 Phase 3 $709M 3
SYRE Spyre Therapeutics DermatologyImmunology Rare 1 Phase 2 $8.91B 10
TTRX Turn Therapeutics DermatologyInfectious Disease Rare 3 Phase 2 $261M 4
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 4 Approved $230M 27
VRCA Verrica Pharmaceuticals DermatologyOncology Rare 3 Approved $53.9M 4
ZBIO Zenas BioPharma DermatologyImmunology+2 Rare 1 NDA Submitted $1.88B 11
ZURA Zura Bio DermatologyImmunology Rare 1 Phase 2 $99.7M 4